BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Response to oxidative stress
,
Pseudomonas infection
,
Heart
,
DNA fingerprint
,
GATA1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Lewis lung carcinoma
Summary
General Info
Curated Studies
Most Correlated Studies
Lewis lung carcinoma grafts in young and middle aged mice
Lewis Lung Carcinoma subclones that stimulated different thermogenic responses in adipocytes
Lung pericytes treated with control or LRG1-overexpressing Lewis lung carcinoma conditioned media
Lewis lung carcinoma model in adolescent, young adult, middle-aged and old mice
Dendritic cells from tumoral and peritumoral lung tissues of mice with Lewis lung carcinoma
Explore Curated Studies Results
Literature
Most Relevant Literature
Metabolomes of Lewis lung carcinoma metastases and normal lung tissue from mice fed different diets.
Erythropoiesis-Stimulating Properties of Anthocyanin-Containing Complex from Sorbus aucuparia L. in …
Neutralizing interleukin-6 in tumor-bearing mice does not abrogate behavioral fatigue induced by Lew…
Dihydroartemisinin inhibits Lewis Lung carcinoma progression by inducing macrophages M1 polarization…
Study on antitumor activities of the chrysin-chromene-spirooxindole on Lewis lung carcinoma C57BL/6 …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma
Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma
Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or…
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamo…
Ramucirumab and Pembrolizumab Versus Standard of Care in Treating Patients With Stage IV or Recurren…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ